← Evidence map

ReviewPharmacoEconomics2018

Ponatinib for Treating Chronic Myeloid Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Abdullah Pandor et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2018

this papercites it

Ponatinib for Treating Chronic Myeloid Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. | OpenQuestion